Effects of hypoxia on an in vitro blood-brain barrier

被引:0
|
作者
Plateel, M
Dehouck, MP
Torpier, G
Fruchart, JP
Cecchelli, R
Teissier, E
机构
来源
BIOLOGY AND PHYSIOLOGY OF THE BLOOD-BRAIN BARRIER: TRANSPORT, CELLULAR INTERACTIONS, AND BRAIN PATHOLOGIES | 1996年 / 46卷
关键词
D O I
暂无
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Using a cell culture model of the BBB, we investigated the brain capillary ECs response to hypoxia. ECs contain the same free-radical protecting enzymes and glutathione as isolated capillaries. These anti-oxidant enzymes and GSH are not induced by astrocytes. These results clearly show that ECs could be a relevant model to study the effects of hypoxia at the BBB level. In the time course of hypoxia, free radical detoxifying enzymes and GSH level decrease. Concomittant rearrangements of F-actin of the ECs and a decrease in the ATP level might explain the paracellular permeability increase of the monolayer. An apoptotic process is detected by in situ end labeling of DNA. This suggests that hypoxia alters some functions of the ECs monolayer and increases the susceptibility of the BBB to further oxidative damages.
引用
收藏
页码:323 / 325
页数:3
相关论文
共 50 条
  • [1] Effects of cyclical intermittent hypoxia on the blood-brain barrier
    Lim, D.
    Brady, D.
    Soans, R.
    Kim, E.
    Valverde, L.
    Kim, W.
    Park, M.
    Keenan, B.
    Shackleford, J.
    Pack, A.
    SLEEP MEDICINE, 2015, 16 : S133 - S133
  • [2] Rapid hypoxia/aglycemia compromises in vitro blood-brain barrier integrity
    Abbruscato, TJ
    Davis, TP
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R409 - R409
  • [3] Combination of hypoxia/aglycemia compromises in vitro blood-brain barrier integrity
    Abbruscato, TJ
    Davis, TP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 289 (02): : 668 - 675
  • [4] The effects of pentosan polysulphate on the blood-brain barrier in vitro
    Deli, M. A.
    Abraham, C. S.
    Veszelka, S.
    Niwa, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 106 - 106
  • [5] Effects of arsenolipids on in vitro blood-brain barrier model
    Mueller, S. M.
    Ebert, F.
    Raber, G.
    Meyer, S.
    Bornhorst, J.
    Huwel, S.
    Galla, H. -J.
    Francesconi, K. A.
    Schwerdtle, T.
    ARCHIVES OF TOXICOLOGY, 2018, 92 (02) : 823 - 832
  • [6] Effects of arsenolipids on in vitro blood-brain barrier model
    S. M. Müller
    F. Ebert
    G. Raber
    S. Meyer
    J. Bornhorst
    S. Hüwel
    H.-J. Galla
    K. A. Francesconi
    T. Schwerdtle
    Archives of Toxicology, 2018, 92 : 823 - 832
  • [7] In vitro effects of anaesthetic agents on the blood-brain barrier
    Fischer, S
    Renz, D
    Kleinstück, J
    Schaper, W
    Karliczek, GF
    ANAESTHESIST, 2004, 53 (12): : 1177 - 1184
  • [8] In vitro models for the blood-brain barrier
    Garberg, P
    Ball, M
    Borg, N
    Cecchelli, R
    Fenart, L
    Hurst, RD
    Lindmark, T
    Mabondzo, A
    Nilsson, JE
    Raub, TJ
    Stanimirovic, D
    Terasaki, T
    Öberg, JO
    Österberg, T
    TOXICOLOGY IN VITRO, 2005, 19 (03) : 299 - 334
  • [9] In vitro models of the blood-brain barrier
    Garberg, P
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 1998, 26 (06): : 821 - 847
  • [10] In vitro models of the blood-brain barrier
    Wilhelm, Imola
    Fazakas, Csilla
    Krizbai, Istvan A.
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2011, 71 (01) : 113 - 128